The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Open accessAbstract
Despite 30 years of effort, there is no effective vaccine for HIV-1. However, antibodies can prevent HIV-1 infection in humanized mice and macaques when passively transferred. New single-cell-based methods have uncovered many broad and potent donor-derived antibodies, and structural studies have revealed the molecular bases for their activities. The new data suggest why such antibodies are difficult to elicit and inform HIV-1 vaccine development efforts. In addition to protecting against infection, the newly identified antibodies can suppress active infections in mice and macaques, suggesting they could be valuable additions to anti-HIV-1 therapies and to strategies to eradicate HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Self-citationVictora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Self-citationRational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Self-citationStructural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Self-citationTrkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Sanders, R. W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., de Val, N., Kim, H. J., Blattner, C., de la Peña, A. T., Korzun, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003618 · Cited by 935
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Self-citationDaar, E. S., Moudgil, T., Meyer, R. D., & Ho, D. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241405 · Cited by 838
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
Molecular architecture of native HIV-1 gp120 trimers
Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., & Subramaniam, S. (2008) · Nature · doi:10.1038/nature07159 · Cited by 816
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Julien, J.-P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., et al. (2013) · Science · doi:10.1126/science.1245625 · Cited by 797
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Distribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
Simon, V., Ho, D. D., & Abdool Karim, Q. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69157-5 · Cited by 730
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Lyumkis, D., Julien, J.-P., de Val, N., Cupo, A., Potter, C. S., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., Carragher, B., et al. (2013) · Science · doi:10.1126/science.1245627 · Cited by 669
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Cohen, M. S., Shaw, G. M., McMichael, A. J., & Haynes, B. F. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011874 · Cited by 660
The RAG Proteins and V(D)J Recombination: Complexes, Ends, and Transposition
Fugmann, S. D., Lee, A. I., Shockett, P. E., Villey, I. J., & Schatz, D. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.495 · Cited by 647
Barouch, D. H., Whitney, J. B., Moldt, B., Klein, F., Oliveira, T. Y., Liu, J., Stephenson, K. E., Chang, H.-W., Shekhar, K., Gupta, S., et al. (2013) · Nature · doi:10.1038/nature12744 · Cited by 644
Self-citationGoonetilleke, N., Liu, M. K. P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090365 · Cited by 641
Tomaras, G. D., Yates, N. L., Liu, P., Qin, L., Fouda, G. G., Chavez, L. L., Decamp, A. C., Parks, R. J., Ashley, V. C., Lucas, J. T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01708-08 · Cited by 631
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
MECHANISM AND CONTROL OF V(D)J RECOMBINATION AT THE IMMUNOGLOBULIN HEAVY CHAIN LOCUS
Jung, D., Giallourakis, C., Mostoslavsky, R., & Alt, F. W. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115830 · Cited by 578
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
Richman, D. D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S. A., Sullivan, J., Cheeseman, S., Barringer, K., & Pauletti, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1660-1666.1994 · Cited by 576
Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Self-citationAntibody-based protection against HIV infection by vectored immunoprophylaxis
Balazs, A. B., Chen, J., Hong, C. M., Rao, D. S., Yang, L., & Baltimore, D. (2012) · Nature · doi:10.1038/nature10660 · Cited by 545
Klein, F., Diskin, R., Scheid, J. F., Gaebler, C., Mouquet, H., Georgiev, I. S., Pancera, M., Zhou, T., Incesu, R.-B., Fu, B. Z., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.018 · Cited by 537
Self-citationSather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Klein, F., Halper-Stromberg, A., Horwitz, J. A., Gruell, H., Scheid, J. F., Bournazos, S., Mouquet, H., Spatz, L. A., Diskin, R., Abadir, A., et al. (2012) · Nature · doi:10.1038/nature11604 · Cited by 500
Self-citationB-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Batista, F. D., & Neuberger, M. S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80580-4 · Cited by 481
Autoreactivity in Human IgG+ Memory B Cells
Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M. C., & Wardemann, H. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.009 · Cited by 478
Self-citationGray, E. S., Madiga, M. C., Hermanus, T., Moore, P. L., Wibmer, C. K., Tumba, N. L., Werner, L., Mlisana, K., Sibeko, S., Williamson, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00198-11 · Cited by 466
Antibodies in HIV-1 Vaccine Development and Therapy
Klein, F., Mouquet, H., Dosenovic, P., Scheid, J. F., Scharf, L., & Nussenzweig, M. C. (2013) · Science · doi:10.1126/science.1241144 · Cited by 457
Self-citationAntibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Shingai, M., Nishimura, Y., Klein, F., Mouquet, H., Donau, O. K., Plishka, R., Buckler-White, A., Seaman, M., Piatak, M., Lifson, J. D., et al. (2013) · Nature · doi:10.1038/nature12746 · Cited by 455
Self-citationHuman Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Kwong, P. D., & Mascola, J. R. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.012 · Cited by 455
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Mouquet, H., Scheid, J. F., Zoller, M. J., Krogsgaard, M., Ott, R. G., Shukair, S., Artyomov, M. N., Pietzsch, J., Connors, M., Pereyra, F., et al. (2010) · Nature · doi:10.1038/nature09385 · Cited by 427
Self-citationCorti, D., Langedijk, J. P. M., Hinz, A., Seaman, M. S., Vanzetta, F., Fernandez-Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008805 · Cited by 426
Bonsignori, M., Hwang, K.-K., Chen, X., Tsao, C.-Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05045-11 · Cited by 423
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
A Blueprint for HIV Vaccine Discovery
Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., Kaufmann, D. E., McElrath, M. J., Nussenzweig, M. C., Pulendran, B., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.008 · Cited by 375
Self-citationIncreasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Diskin, R., Scheid, J. F., Marcovecchio, P. M., West, A. P., Klein, F., Gao, H., Gnanapragasam, P. N. P., Abadir, A., Seaman, M. S., Nussenzweig, M. C., et al. (2011) · Science · doi:10.1126/science.1213782 · Cited by 375
Self-citationZhou, T., Zhu, J., Wu, X., Moquin, S., Zhang, B., Acharya, P., Georgiev, I. S., Altae-Tran, H. R., Chuang, G.-Y., Joyce, M. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.012 · Cited by 366
Self-citationBinley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., Decker, J. M., Wycuff, D., Harris, L., Hawkins, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01762-08 · Cited by 355
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Kong, L., Lee, J. H., Doores, K. J., Murin, C. D., Julien, J.-P., McBride, R., Liu, Y., Marozsan, A., Cupo, A., Klasse, P.-J., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2594 · Cited by 337
Doria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Lapedes, A., Bhattacharya, T., Migueles, S. A., Wyatt, R. T., Korber, B. T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01482-09 · Cited by 336
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
Kwong, P. D., Mascola, J. R., & Nabel, G. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3516 · Cited by 329
Identifying epitopes of HIV-1 that induce protective antibodies
Zolla-Pazner, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1307 · Cited by 326
Doria-Rose, N. A., Klein, R. M., Manion, M. M., O'Dell, S., Phogat, A., Chakrabarti, B., Hallahan, C. W., Migueles, S. A., Wrammert, J., Ahmed, R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01583-08 · Cited by 318
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Mikell, I., Sather, D. N., Kalams, S. A., Altfeld, M., Alter, G., & Stamatatos, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001251 · Cited by 315
Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process
Reynaud, C.-A., Garcia, C., Hein, W. R., & Weill, J.-C. (1995) · Cell · doi:10.1016/0092-8674(95)90456-5 · Cited by 314
McGuire, A. T., Hoot, S., Dreyer, A. M., Lippy, A., Stuart, A., Cohen, K. W., Jardine, J., Menis, S., Scheid, J. F., West, A. P., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122824 · Cited by 309
Self-citationGorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Emini, E. A., Koenig, S., & Zolla-Pazner, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7538-7542.1992 · Cited by 308
Sagar, M., Wu, X., Lee, S., & Overbaugh, J. (2006) · Journal of Virology · doi:10.1128/jvi.00141-06 · Cited by 308
Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection
Gray, E. S., Moore, P. L., Choge, I. A., Decker, J. M., Bibollet-Ruche, F., Li, H., Leseka, N., Treurnicht, F., Mlisana, K., Shaw, G. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00239-07 · Cited by 299
Julien, J.-P., Sok, D., Khayat, R., Lee, J. H., Doores, K. J., Walker, L. M., Ramos, A., Diwanji, D. C., Pejchal, R., Cupo, A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003342 · Cited by 293
Chertova, E., Bess, Crise, B. J., Sowder, R. C., Schaden, T. M., Hilburn, J. M., Hoxie, J. A., Benveniste, R. E., Lifson, J. D., Henderson, L. E., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5315-5325.2002 · Cited by 290
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
Moore, P. L., Gray, E. S., Wibmer, C. K., Bhiman, J. N., Nonyane, M., Sheward, D. J., Hermanus, T., Bajimaya, S., Tumba, N. L., Abrahams, M.-R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2985 · Cited by 285
Sun, Z.-Y. J., Oh, K. J., Kim, M., Yu, J., Brusic, V., Song, L., Qiao, Z., Wang, J.-H., Wagner, G., & Reinherz, E. L. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.018 · Cited by 279
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., & Burton, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1252-1261.2005 · Cited by 278
Few and Far Between: How HIV May Be Evading Antibody Avidity
Klein, J. S., & Bjorkman, P. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000908 · Cited by 271
Self-citationHorwitz, J. A., Halper-Stromberg, A., Mouquet, H., Gitlin, A. D., Tretiakova, A., Eisenreich, T. R., Malbec, M., Gravemann, S., Billerbeck, E., Dorner, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315295110 · Cited by 271
Self-citationStructural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
Pancera, M., Shahzad-ul-Hussan, S., Doria-Rose, N. A., McLellan, J. S., Bailer, R. T., Dai, K., Loesgen, S., Louder, M. K., Staupe, R. P., Yang, Y., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2600 · Cited by 270
Kinetic maturation of an immune response
Foote, J., & Milstein, C. (1991) · Nature · doi:10.1038/352530a0 · Cited by 269
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Role of HIV membrane in neutralization by two broadly neutralizing antibodies
Alam, S. M., Morelli, M., Dennison, S. M., Liao, H.-X., Zhang, R., Xia, S.-M., Rits-Volloch, S., Sun, L., Harrison, S. C., Haynes, B. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908713106 · Cited by 250
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Julien, J.-P., Lee, J. H., Cupo, A., Murin, C. D., Derking, R., Hoffenberg, S., Caulfield, M. J., King, C. R., Marozsan, A. J., Klasse, P. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217537110 · Cited by 247
Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo
Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W. H. I., Mosier, D. E., & Burton, D. R. (1999) · Immunity · doi:10.1016/s1074-7613(00)80043-6 · Cited by 243
West, A. P., Diskin, R., Nussenzweig, M. C., & Bjorkman, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208984109 · Cited by 231
Self-citationA fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
Frey, G., Peng, H., Rits-Volloch, S., Morelli, M., Cheng, Y., & Chen, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800255105 · Cited by 222
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
Georgiev, I. S., Doria-Rose, N. A., Zhou, T., Do Kwon, Y., Staupe, R. P., Moquin, S., Chuang, G.-Y., Louder, M. K., Schmidt, S. D., Altae-Tran, H. R., et al. (2013) · Science · doi:10.1126/science.1233989 · Cited by 212
Verkoczy, L., Diaz, M., Holl, T. M., Ouyang, Y.-B., Bouton-Verville, H., Alam, S. M., Liao, H.-X., Kelsoe, G., & Haynes, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912914107 · Cited by 190
Prevention of HIV Infection by Passive Immunization with HIV Immunoglobulin
PRINCE, A. M., REESINK, H., PASCUAL, D., HOROWITZ, B., HEWLETT, I., MURTHY, K. K., COBB, K. E., & EICHBERG, J. W. (1991) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1991.7.971 · Cited by 190
Walker, B., & McMichael, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007054 · Cited by 189
Wibmer, C. K., Bhiman, J. N., Gray, E. S., Tumba, N., Abdool Karim, S. S., Williamson, C., Morris, L., & Moore, P. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003738 · Cited by 185
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
Hoot, S., McGuire, A. T., Cohen, K. W., Strong, R. K., Hangartner, L., Klein, F., Diskin, R., Scheid, J. F., Sather, D. N., Burton, D. R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003106 · Cited by 184
Self-citationEarly Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape
Bar, K. J., Tsao, C.-Y., Iyer, S. S., Decker, J. M., Yang, Y., Bonsignori, M., Chen, X., Hwang, K.-K., Montefiori, D. C., Liao, H.-X., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002721 · Cited by 180
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies
Yang, G., Holl, T. M., Liu, Y., Li, Y., Lu, X., Nicely, N. I., Kepler, T. B., Alam, S. M., Liao, H.-X., Cain, D. W., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121977 · Cited by 174
Nelson, J. D., Brunel, F. M., Jensen, R., Crooks, E. T., Cardoso, R. M. F., Wang, M., Hessell, A., Wilson, I. A., Binley, J. M., Dawson, P. E., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02588-06 · Cited by 172
Wagner, S. D., Milstein, C., & Neuberger, M. S. (1995) · Nature · doi:10.1038/376732a0 · Cited by 169
Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV
Goldberg, D. E., Siliciano, R. F., & Jacobs, W. R. (2012) · Cell · doi:10.1016/j.cell.2012.02.021 · Cited by 168
Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
Malbec, M., Porrot, F., Rua, R., Horwitz, J., Klein, F., Halper-Stromberg, A., Scheid, J. F., Eden, C., Mouquet, H., Nussenzweig, M. C., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131244 · Cited by 166
Self-citationIgarashi, T., Brown, C., Azadegan, A., Haigwood, N., Dimitrov, D., Martin, M. A., & Shibata, R. (1999) · Nature Medicine · doi:10.1038/5576 · Cited by 164
Klein, J. S., Gnanapragasam, P. N. P., Galimidi, R. P., Foglesong, C. P., West, A. P., & Björkman, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811427106 · Cited by 163
Self-citationPrefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy
Bartesaghi, A., Merk, A., Borgnia, M. J., Milne, J. L. S., & Subramaniam, S. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2711 · Cited by 161
Klein, F., Gaebler, C., Mouquet, H., Sather, D. N., Lehmann, C., Scheid, J. F., Kraft, Z., Liu, Y., Pietzsch, J., Hurley, A., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120423 · Cited by 159
Self-citationMeffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Self-citationNeutralizing antibodies to HIV-1 induced by immunization
McCoy, L. E., & Weiss, R. A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121827 · Cited by 140
Polyreactive antibodies in adaptive immune responses to viruses
Mouquet, H., & Nussenzweig, M. C. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0872-6 · Cited by 128
Self-citationWest, A. P., Scharf, L., Horwitz, J. A., Klein, F., Nussenzweig, M. C., & Björkman, P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309215110 · Cited by 125
Self-citationMehandru, S., Vcelar, B. A., Wrin, T., Stiegler, G. M., Joos, B., Mohri, H., Boden, D., Galovich, J., Tenner‐Racz, K., Rácz, P., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01340-07 · Cited by 120
TILLEY, S. A., Honnen, W. J., RACHO, M. E., Hilgartner, M. W., & Pinter, A. (1991) · Research in Virology · doi:10.1016/0923-2516(91)90010-z · Cited by 118
West, A. P., Diskin, R., Nussenzweig, M. C., & Björkman, P. J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s2-o33 · Cited by 114
Self-citationOfek, G., McKee, K., Yang, Y., Yang, Z., Skinner, J., Guenaga, J., Wyatt, R. T., Zwick, M. B., Nabel, G. J., Mascola, J. R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02257-09 · Cited by 111
Lefranc, M. (2011) · Cold Spring Harbor Protocols · doi:10.1101/pdb.ip85 · Cited by 107
Scott, C. F., Silver, S., Profy, A. T., Putney, S. D., Langlois, A. J., Weinhold, K. J., & Robinson, J. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8597 · Cited by 105
Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies
Diskin, R., Klein, F., Horwitz, J. A., Halper-Stromberg, A., Sather, D. N., Marcovecchio, P., Lee, T., West, A. P., Gao, H., Seaman, M. S., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130221 · Cited by 104
Self-citationvan Gils, M. J., Bunnik, E. M., Boeser‐Nunnink, B., Burger, J. A., Terlouw-Klein, M., Verwer, N., & Schuitemaker, H. (2011) · Journal of Virology · doi:10.1128/jvi.00268-11 · Cited by 101
Walker, L. M., Sok, D., Nishimura, Y., Donau, O. K., Sadjadpour, R., Gautam, R., Shingai, M., Pejchal, R., Ramos, A. G., Simek, M. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117531108 · Cited by 84
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
Huang, K. G., Bonsall, D., Katzourakis, A., Thomson, E. C., Fidler, S. J., Main, J., Muir, D. A., Weber, J. N., Frater, A. J., Phillips, R. E., et al. (2010) · Nature Communications · doi:10.1038/ncomms1100 · Cited by 82
Verkoczy, L. K., Yao, C., Zhang, J., Bouton-Verville, H., Newman, A., Lockwood, B., Scearce, R. M., Montefiori, D. C., Dennison, S. M., Xia, S.-M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300971 · Cited by 79
Shingai, M., Donau, O. K., Schmidt, S. D., Gautam, R., Plishka, R. J., Buckler-White, A. J., Sadjadpour, R., Lee, W. R., LaBranche, C. C., Montefiori, D. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217443109 · Cited by 75
Alam, S. M., Dennison, S. M., Aussedat, B., Vohra, Y., Park, P. K., Fernández‐Tejada, A., Stewart, S. M., Jaeger, F. H., Anasti, K. M., Blinn, J. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317855110 · Cited by 74
HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
Cortez, V. A., Odem‐Davis, K., McClelland, R. S., Jaoko, W. G., & Overbaugh, J. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002611 · Cited by 72
Hamlyn, E., Ewings, F. M., Porter, K., Cooper, D. A., Tambussi, G., Schechter, M., Pedersen, C., Okulicz, J. F., McClure, M., Babiker, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043754 · Cited by 71
Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral Strains
Chuang, G., Acharya, P., Schmidt, S. D., Yang, Y., Louder, M. K., Zhou, T., Kwon, Y. D., Pancera, M., Bailer, R. T., Doria‐Rose, N. A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00984-13 · Cited by 68
Self-citationPietzsch, J., Scheid, J. F., Mouquet, H., Klein, F., Seaman, M. S., Janković, M., Corti, D., Lanzavecchia, A., & Nussenzweig, M. C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101176 · Cited by 67
Self-citationCorrection: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
Hoot, S., McGuire, A. T., Cohen, K. W., Strong, R. K., Hangartner, L., Klein, F., Diskin, R., Scheid, J. F., Sather, D. N., Burton, D. R., et al. (2013) · PLoS Pathogens · doi:10.1371/annotation/ed7c0148-97eb-4416-824d-6e6d1aaeceef · Cited by 62
Self-citationEnhanced HIV-1 neutralization by antibody heteroligation
Mouquet, H., Warncke, M. L., Scheid, J. F., Seaman, M. S., & Nussenzweig, M. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120059109 · Cited by 59
Self-citationAdvances in antiretroviral therapy
Arribas, J. R., & Eron, J. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328361fabd · Cited by 55
West, A. P., Galimidi, R. P., Foglesong, C. P., Gnanapragasam, P. N. P., Huey‐Tubman, K. E., Klein, J. S., Suzuki, M. D., Tiangco, N. E., Vielmetter, J., & Björkman, P. J. (2008) · Journal of Virology · doi:10.1128/jvi.01564-08 · Cited by 52
Self-citationde Silva, T. I., Aasa-Chapman, M. M. I., Cotten, M. L., Hué, S., Robinson, J., Bibollet‐Ruche, F., Sarge‐Njie, R., Berry, N. J., Jaye, A., Aaby, P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06126-11 · Cited by 51
Finton, K. A. K., Larimore, K., Larman, H. B., Friend, D. J., Correnti, C., Rupert, P. B., Elledge, S. J., Greenberg, P. D., & Strong, R. K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003639 · Cited by 51
Gautam, R., Nishimura, Y., Lee, W. R., Donau, O. K., Buckler-White, A. J., Shingai, M., Sadjadpour, R., Schmidt, S. D., LaBranche, C. C., Keele, B. F., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00644-12 · Cited by 50
Sather, D. N., Carbonetti, S., Kehayia, J., Kraft, Z., Mikell, I., Scheid, J. F., Klein, F., & Stamatatos, L. (2012) · Journal of Virology · doi:10.1128/jvi.01893-12 · Cited by 48
Self-citationPlasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
Davey, R. T., Dewar, R. L., Reed, G. F., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5608 · Cited by 46
Wu, Y., West, A. P., Kim, H. J., Thornton, M. E., Ward, A. C., & Björkman, P. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.015 · Cited by 45
Self-citationPancera, M., Yang, Y., Louder, M. K., Gorman, J., Lu, G., McLellan, J. S., Stuckey, J., Zhu, J., Burton, D. R., Koff, W. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055701 · Cited by 40
Passive Immunization as Tool to Identify Protective HIV-1 Env Epitopes
Kramer, V. G., Siddappa, N. B., & Ruprecht, R. M. (2007) · Current HIV Research · doi:10.2174/157016207782418506 · Cited by 34
Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies
Kong, R., Li, H., Georgiev, I. S., Changela, A., Bibollet‐Ruche, F., Decker, J. M., Rowland‐Jones, S., Jaye, A., Guan, Y., Lewis, G. K., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01632-12 · Cited by 27
Gruell, H., Bournazos, S., Ravetch, J. V., Ploß, A., Nussenzweig, M. C., & Pietzsch, J. (2013) · Journal of Virology · doi:10.1128/jvi.00868-13 · Cited by 27
Self-citationAdvances in antiretroviral therapy.
Taylor, B., Sk, O., Wilkin, T. J., et al. (2012) · PubMed · Cited by 25
Vergidis, P. I., Falagas, M. E., & Hamer, D. H. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.01.013 · Cited by 24
New templates for HIV-1 antibody-based vaccine design
Sattentau, Q. J., & McMichael, A. J. (2010) · F1000 Biology Reports · doi:10.3410/b2-60 · Cited by 24
Löving, R., Sjöberg, M., Wu, S.-R., Binley, J. Μ., & Garoff, H. (2013) · Journal of Virology · doi:10.1128/jvi.00530-13 · Cited by 14
Cited by
Vinuesa, C. G., Linterman, M. A., Yu, D., & MacLennan, I. C. M. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055605 · Cited by 1,141
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., Kremer, G., Nogueira, L., Braunschweig, M., Scheid, J. F., et al. (2015) · Nature · doi:10.1038/nature14411 · Cited by 767
Self-citationDeeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 644
Clonal selection in the germinal centre by regulated proliferation and hypermutation
Gitlin, A. D., Shulman, Z., & Nussenzweig, M. C. (2014) · Nature · doi:10.1038/nature13300 · Cited by 591
Self-citationHIV-1 neutralizing antibodies induced by native-like envelope trimers
Sanders, R. W., van Gils, M. J., Derking, R., Sok, D., Ketas, T. J., Burger, J. A., Ozorowski, G., Cupo, A., Simonich, C., Goo, L., et al. (2015) · Science · doi:10.1126/science.aac4223 · Cited by 496
Metadata
- Authors
- West, A. P., Scharf, L., Scheid, J. F., Klein, F., Bjorkman, P. J., & Nussenzweig, M. C.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 156
- Issue
- 4
- Pages
- 633-648
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2037320559
- Cited by
- 321
- References
- 149
- FWCI
- 25.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.